Replies to post #249559 on Biotech Values

[vinmantoo]

GSK’s bepirovirsen both alone and in combination with nucleos(t)ide analogue therapy has shown functional cure in patients with chronic hepatitis B
Addition of JNJ-3989 when administered sequentially with bepirovirsen may have the potential to further increase functional cure rates

Thanks. Nice bit of creative writing here. Saying it is a functional cure would be accurate if it had a very high rate of such an outcome not a few percentage of the patients.